Abstracts tagged "CPPD"

Abstract Number: 1583 • ACR Convergence 2021
Creation of an Ultrasonographic Scoring System for CPPD Extent: Results from a Delphi Process by the OMERACT US Working Group – CPPD Subgroup
Silvia Sirotti¹, Antonella Adinolfi², Fabio Becce³, Tomas Cazenave⁴, Sara Nysom Christiansen⁵, Edoardo Cipolletta⁶, Andrea Delle Sedie⁷, Mario Enrique Diaz Cortes⁸, Fabiana Figus⁹, Emilio Filippucci¹⁰, Peter Mandl¹¹, Daryl MacCarter¹², Ingrid Moller¹³, Mohamed Mortada¹⁴, Gael Mouterde¹⁵, Maria Esperanza Naredo Sanchez¹⁶, Carlos Pineda¹⁷, Francesco Porta¹⁸, Wolfgang Schmidt¹⁹, Teodora Serban²⁰, Lene Terslev²¹, Florentin Vreju²², Richard Wakefield²³, Pascal Zufferey²⁴, Piercarlo Sarzi-Puttini²⁵, Maria-Antonietta D'Agostino²⁶, Nemanja Damjanov²⁷, Annamaria Iagnocco²⁸, Helen Keen²⁹ and Georgios Filippou³⁰, ¹Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy, ²Rheumatology Unit, Grande Ospedale Metropolitano Niguarda, Milan, Italy, ³Lausanne University Hospital, Lausanne, Switzerland, ⁴Instituto de Rehabilitación Psicofisica, Buenos Aires, Argentina, Buenos Aires, Argentina, ⁵Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark, ⁶Polytechnic University of Marche, Jesi, Italy, ⁷University of Pisa, Pisa, Italy, ⁸Rheumatology Unit, University Hospital Fundación Santa Fe de Bogota, Bogotà, Colombia, ⁹University of Torino, Torino, Italy, ¹⁰Rheumatology Unit, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Jesi, Italy, ¹¹Medical University of Vienna, Vienna, Austria, ¹²Rheumatology Department, North Valley Hospital, Whitefish, MT, ¹³University of Barcelona, Barcelona, Spain, ¹⁴Zagazig University, Zagazig, Egypt, ¹⁵Rheumatology department, CHU Montpellier, Montpellier, France, ¹⁶Department of rheumatology, Joint and Bone research Unit, Hospital Universitario Fundación Jiménez díaz and Autónoma University, Madrid, Spain, ¹⁷Instituto Nacional de Rehabilitacion, Mexico City, Federal District, Mexico, ¹⁸INS, Institute of Neurosciences, Florence, Italy, ¹⁹Immanuel Krankenhaus Berlin, Berlin, Germany, ²⁰ASL 3 Genovese, Genova, Italy, ²¹Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University, Glostrup, Denmark, ²²Rheumatology Department, University of Medicine and Pharmacy of Craiova, Craiova, Romania, ²³Rheumatology, Leeds University, Leeds, United Kingdom, ²⁴Rheumatology Department, University of Lausanne, CHUV, Lausanne, Switzerland, ²⁵L.Sacco University Hospital, Milano, Italy, ²⁶Rheumatology Department, Università Cattolica del Sacro Cuore, Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy, ²⁷University of Belgrade School of Medicine, Institute of Rheumatology, Belgrade, Serbia, ²⁸University of Turin, Roma, Italy, ²⁹University of Western Australia, Daglish, Australia, ³⁰Rheumatology Department, Luigi Sacco University Hospital, Siena, Italy
Background/Purpose: Ultrasound (US) has proven to be an excellent technique for detecting Calcium Pyrophosphate (CPP) deposits, however there are no grading systems that allow for…
Abstract Number: 1898 • ACR Convergence 2021
Risk of Major Adverse Cardiovascular Events in a Large Cohort of Patients with Acute Calcium Pyrophosphate Crystal Arthritis
Sara Tedeschi¹, Weixing Huang¹, Kazuki Yoshida¹ and Daniel Solomon², ¹Brigham and Women's Hospital, Boston, MA, ²Brigham and Women's Hospital, Newton, MA
Background/Purpose: Acute calcium pyrophosphate (CPP) crystal arthritis, also known as pseudogout, causes an acute inflammatory arthritis that shares clinical similarities with gout. We investigated the…
Abstract Number: 0669 • ACR Convergence 2020
Calcium Pyrophosphate Crystal Deposition in Gouty Tophi
Hang-Korng Ea¹, Alan Gauffenic², Quand Nguyen³, Nhu Pham³, Oceane Olivier², Vincent Frochot⁴, Dominique Bazin⁵, Nghia Le³, Caroline Marty², Agnès Ostertag², Martine Cohen-Solal¹, Jean-Denis Laredo⁶, Pascal Richette⁷ and Thomas Bardin⁸, ¹Université de Paris, INSERM UMR 1132, BIOSCAR, AP-HP, DMU Locomoteur, Paris, France, ²Université de Paris, INSERM UMR 1132, BIOSCAR, Paris, France, ³Vien Gut Medical Center and French-Vietnamese research center on gout and chronic diseases, Ho Chi Ming, Vietnam, ⁴Hôpital Tenon, Service des explorations fonctionnelles multidisciplinaires, Sorbonne université, UMR_S1155, Paris, France, ⁵Institut de Chimie Physique, Université Paris-Saclay et CNRS - UMR8000, Orsay, France, ⁶AP-HP Université de Paris, Paris, ⁷Department of Rheumatology, Lariboisière Hospital, AP-HP Université de Paris, INSERM U1132, Paris, ⁸Université de Paris, INSERM U1132 and Hôpital Lariboisièe, Paris, France, Paris, France
Background/Purpose: The coexistence of calcium pyrophosphate (CPP) and monosodium urate crystals is rarely reported in gouty tophi. We investigated CPP crystal deposits in a series…
Abstract Number: 0670 • ACR Convergence 2020
Risk Factors for Pseudogout: An Electronic Medical Record Case-Control Study
Sara Tedeschi¹, Kazuki Yoshida¹, Weixing Huang² and Daniel H. Solomon¹, ¹Brigham & Women's Hospital and Harvard Medical School, Boston, MA, ²Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School, Boston
Background/Purpose: Prior studies of calcium pyrophosphate crystal deposition disease (CPPD) epidemiology either focused on the entire spectrum of CPPD or identified patients with its acute…
Abstract Number: 1542 • ACR Convergence 2020
The Role of Dual Energy Computed Tomography (DECT) in the Differentiation of Gout and Calcium Pyrophosphate Deposition Disease
Dmitrij Kravchenko¹, Pantelis Karakostas², Peter Brossart³, Charlotte Behning⁴, Carsten Meyer¹ and Valentin Schaefer⁵, ¹Department of Interventional and Diagnostic Radiology, University Hospital Bonn, Bonn, Germany, Bonn, Germany, ²Clinic for Internal Medicine III, Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany, Bonn, Germany, ³Clinic for Internal Medicine III, Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Germany, Bonn, Nordrhein-Westfalen, Germany, ⁴Institute for Medical Biometrics, Informatics and Epidemiology (IMBIE), University Hospital Bonn, Bonn, Germany, Bonn, Nordrhein-Westfalen, Germany, ⁵Clinic ofInternal Medicine III, Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany, Bonn, Germany
Background/Purpose: Differentiation of gout and calcium pyrophosphate deposition disease (CPPD) is sometimes difficult as patients often present with a similar clinical picture. Arthrocentesis and subsequent…
Abstract Number: 0666 • ACR Convergence 2020
Identification of Intracellular Vacuoles in Synovial Fluid with Calcium Pyrophosphate and Monosodium Urate Crystals
Maria Luisa Peral¹, Irene Calabuig¹, Ana Martín-Carratalá², Mariano Andrés¹ and Eliseo Pascual¹, ¹Hospital General Universitario de Alicante-ISABIAL and Universidad Miguel Hernández de Elche, Alicante, Spain, ²Universidad Miguel Hernández de Elche, Alicante
Background/Purpose: Synovial fluid analysis using polarized microscopy is the gold standard for the diagnosis of crystal-related arthritis. In our experience, we have noted that, when…
Abstract Number: 0668 • ACR Convergence 2020
Outcomes and Resource Utilization After Total Knee Arthroplasty in Calcium Pyrophosphate Crystal Deposition Disease Patients: Insights from the National Inpatient Sample Database
Konstantinos Parperis¹, Mohanad Hadi² and Bikash Bhattarai³, ¹University of Arizona College of Medicine Phoenix and University of Cyprus Medical School, Phoenix, ²Creighton University - Maricopa Medical Center/ Valleywise Health Medical Center, Phoenix, AZ, ³Valleywise Health, University of Arizona College of Medicine, Phoenix, AZ
Background/Purpose: Total knee arthroplasty (TKA) is one of the most frequently performed orthopedic procedures in patients with joint cartilage destruction. Calcium pyrophosphate crystal deposition (CPPD)…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].